glp-1 and gip mechanism of action The Effects Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion—A Review GIP and GLP-1: similarities and

Merck Partners with Hansoh Pharma on Oral GLP-1 Receptor Agonist for Type 2 Diabetes Merck has entered into an exclusive global license agreement with Hansoh Pharma to develop and commercialize HS-10270, an investigational oral GLP-1 receptor agonist for the treatment of type 2 diabetes and obesity

Dihexa is now scheduled for PCAC review before the end of February 2027, alongside four other peptides: LL-37, GHK-Cu, PEG-MGF, and Melanotan II

These options may include injectable products and noninjectable products, such as orally disintegrating tablets (tablets that dissolve in the mouth), sublingual tablets (tablets placed under the tongue to dissolve), or oral drops

Specifically, our published data confirms that exendin-4, significantly improves ALD pathology by reducing hepatic steatosis, inflammation, and oxidative stress in experimental rats (Mahalingam et al., 2023)

Eli Lilly took a step in the right direction recently by lowering the price of single-dose Zepbound vials by about $50

Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgery